BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36428747)

  • 1. A Novel Immune-Related Gene Prognostic Index (IRGPI) in Pancreatic Adenocarcinoma (PAAD) and Its Implications in the Tumor Microenvironment.
    Zhou S; Szöllősi AG; Huang X; Chang-Chien YC; Hajdu A
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.
    Wang C; Lu T; Xu R; Chang X; Luo S; Peng B; Wang J; Yao L; Wang K; Shen Z; Zhao J; Zhang L
    J Thorac Dis; 2022 Jun; 14(6):2131-2146. PubMed ID: 35813746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer.
    Sun Y; Wang X; Yao L; He R; Man C; Fan Y
    Front Oncol; 2024; 14():1246308. PubMed ID: 38375157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of tumor microenvironment and programmed death-related genes to identify molecular subtypes and drug resistance in pancreatic cancer.
    Yu L; He R; Cui Y
    Front Pharmacol; 2023; 14():1146280. PubMed ID: 37007021
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
    Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
    Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune-related gene prognostic index (IRGPI) for lung adenocarcinoma predicts patient prognosis and immunotherapy response.
    Zhu Z; Feng W; Tan XY; Gu PC; Song W; Ma HT
    Int J Clin Exp Pathol; 2023; 16(10):260-281. PubMed ID: 37970331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.
    Jin Y; Deng J; Luo B; Zhong Y; Yu S
    Front Endocrinol (Lausanne); 2022; 13():963382. PubMed ID: 36440228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping the immunological battlefield in gastric cancer: prognostic implications of an immune gene expression signature.
    Meng X; Wang D; Sun X; Yuan J; Han J
    Discov Oncol; 2023 Nov; 14(1):212. PubMed ID: 37999824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
    Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
    Front Genet; 2021; 12():702102. PubMed ID: 34335699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.
    Wu X; Jin B; Liu X; Mao Y; Wan X; Du S
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10319-10333. PubMed ID: 37273105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma.
    Yan J; Wu X; Yu J; Kong Y; Cang S
    Front Immunol; 2022; 13():839901. PubMed ID: 35280982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusing WGCNA and Machine Learning for Immune-Related Gene Prognostic Index in Lung Adenocarcinoma: Precision Prognosis, Tumor Microenvironment Profiling, and Biomarker Discovery.
    He J; Luan T; Zhao G; Yang Y
    J Inflamm Res; 2023; 16():5309-5326. PubMed ID: 38026246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.
    Wang Z; Song J; Azami NLB; Sun M
    Front Immunol; 2022; 13():802665. PubMed ID: 35572595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer.
    Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
    Front Immunol; 2022; 13():845093. PubMed ID: 35558081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma.
    Xue S; Ge W; Wang K; Mao T; Zhang X; Xu H; Wang Y; Yao J; Li S; Yue M; Ma J; Wang Y; Shentu D; Cui J; Wang L
    Front Cell Dev Biol; 2022; 10():942225. PubMed ID: 36003146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.